Reuters -- A two-in-one prostate drug from GlaxoSmithKline (GSK.L) has won approval in Switzerland, its first European market, the British-based drugmaker said on Monday.
Reuters -- A two-in-one prostate drug from GlaxoSmithKline (GSK.L) has won approval in Switzerland, its first European market, the British-based drugmaker said on Monday.
